<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191230045947N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-19</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>TARGET Efficacy</public_title>
      <acronym></acronym>
      <scientific_title>The Efficacy of TARGET Model in Reducing Anxiety Symptoms and Correlates of Trauma among Women with Anxiety Disorders who had histories of Childhood Trauma</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44619</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is simple. After the initial screening, 40 people who meet the inclusion criteria and gave informed consent to participate in the study are selected. The Online randomization method is used to create randomization sequences. The randomization unit is an individual, and the GraphpaPad website is the randomization tool. In order to allocation concealment, central randomization method is used. That is, the randomization sequence is provided to the Kolahdooz center, and the researcher, based on the order in which the participants enter the study, communicates with the relevant center and, in the case of the random allocation of the participant, is assigned to the participant. Communication methods include the use of phone or text messages.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Anxiety Disorders. Condition 2: Childhood Trauma.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: TARGET Group Therapy. TARGET (Trauma Affect Regulation: Guide for Education and Therapy) is one of the new methods of cognitive-behavioral therapy, useful for traumatic disorders. This method trains emotional self-regulation skills for survivors of trauma. This program includes 7 skills, called 7 steps towards FREEDOM, and each of the FREEDOM letters is representative of one skill. According to the group's Manual, the patients participate in 10 sessions (90-minute each session) of emotional self-regulation skills and stress management. These sessions hold once per week. Intervention 2: Control group: Psychiatric medications. Patients with anxiety disorders who visit a psychiatrist receive their medications depending on the type and severity of the disorder. The most common prescriptions for these patients are Citalopram 20, once per night; Chlorodiazepoxide 10, once per night; S Citalopram 10, once per night; Clonazepam 1, once per night; Gabapentin 100 capsules, consuming in the morning, noon, and at night. The duration of usage, depending on the severity of the disorder and after the control of symptoms, lasts for six months to one year in for stabilization.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is The sensitivity of trauma and confidentiality of patients' information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Narges Barzgar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Clinical psychology department, University of social welfare and rehabilitation sciences, koodakyar, daneshjoo blvd, evin, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۸۵۷۱۳۸۳۴</zip>
        <telephone>+98 21 2218 0045</telephone>
        <email>Narkises73@gmail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Narges Barzgar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Clinical psychology department, University of social welfare and rehabilitation sciences, koodakyar, daneshjoo blvd, evin, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۸۵۷۱۳۸۳۴</zip>
        <telephone>+98 21 2218 0045</telephone>
        <email>Narkises73@gmail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>History of childhood trauma
suffering from an anxiety disorder
Severity of anxiety ranging from 20 to 53 in Spielberger Anxiey Questionnaire
Informed Consent
Female gender
ages 18 to 65</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having severe mental disorders including Schizophrenia spectrum and  Bipolar; Antisocial, Borderline, Paranoid, and Schizotypal Personality Disorders
Having severe personality disorders including antisocial, borderline, paranoid, and schizotypal personality disorders
Evidence of cognitive impairments (orientation, attention, and impaired memory in Mini–mental state examination- MMSE)
Hospitalization in a psychiatric hospital in the last month
Participate in another psychological treatment at the same time</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F40</hc_code>
      <hc_code>F93.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Phobic anxiety disorders</hc_keyword>
      <hc_keyword>Childhood emotional disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: TARGET Group Therapy. TARGET (Trauma Affect Regulation: Guide for Education and Therapy) is one of the new methods of cognitive-behavioral therapy, useful for traumatic disorders. This method trains emotional self-regulation skills for survivors of trauma. This program includes 7 skills, called 7 steps towards FREEDOM, and each of the FREEDOM letters is representative of one skill. According to the group's Manual, the patients participate in 10 sessions (90-minute each session) of emotional self-regulation skills and stress management. These sessions hold once per week.</i_keyword>
      <i_keyword>Control group: Psychiatric medications. Patients with anxiety disorders who visit a psychiatrist receive their medications depending on the type and severity of the disorder. The most common prescriptions for these patients are Citalopram 20, once per night; Chlorodiazepoxide 10, once per night; S Citalopram 10, once per night; Clonazepam 1, once per night; Gabapentin 100 capsules, consuming in the morning, noon, and at night. The duration of usage, depending on the severity of the disorder and after the control of symptoms, lasts for six months to one year in for stabilization.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety level based of Spiel Berger's Inventory (STAI). Timepoint: Before the intervention, 2 weeks after the intervention, 2 months later in the follow-up. Method of measurement: Spiel Berger's Anxiety Questionnaire (STAI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Depression score. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: Beck Depression Inventory-II (BDI-II).</sec_outcome>
      <sec_outcome>Posttraumatic Cognitions. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: Posttraumatic Cognitions Inventory- 9 item (PTCI-9).</sec_outcome>
      <sec_outcome>Coping Strategies. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: COPE-brief.</sec_outcome>
      <sec_outcome>Emotion Dysregulation. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: ِDifficulties in Emotion Regulation Scale (DERS-16).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-25</approval_date>
        <contact_name>Ethics committee of University of Social Welfare and Rehabilitation Sciences</contact_name>
        <contact_address>kodakyar Ave., daneshjo Blvd.,Evin Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
